We serve Chemical Name:2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE CAS:60547-97-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE
CAS.NO:60547-97-9
Synonyms:MFCD00563872;6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine;2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE
Molecular Formula:C14H19N5O2
Molecular Weight:289.33300
HS Code:2933499090
Physical and Chemical Properties:
Melting point:219-221ºC (dec.)
Boiling point:527ºC at 760 mmHg
Density:1.265 g/cm3
Index of Refraction:1.63
PSA:85.53000
Exact Mass:289.15400
LogP:1.61380
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00563872 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE Use and application,2-PIPERAZINE – 4- AMINO – 6,7 DIMETHOXYQUINAZOLINE technical grade,usp/ep/jp grade.
Related News: Joan Merrill, Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Research Program, US, said: “Arthritis and rash are the most common and persistent problems in lupus and often have a significant impact on a person’s life. The strength of the data from this analysis is that anifrolumab was found to be consistently effective using three different ways of looking at rash and three different approaches to arthritis. (S)-3-(2,2,4-trihydroxy-24,44-hexaoxan-4-yl)-14,23-trioxid-1-en-1-one hydrate manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. (S)-6-(5-chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-yl 4-acetylpiperazine-1-carboxylate suppliers The current government-approved antibodies, which are all IgG antibodies, are administered intravenously at high doses and don’t directly target the main sites of viral infection. N-(4-(bis(4-(methyl(phenyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)-N-methylbenzenaminium bromide vendor & factory.
